Molecular and Cellular Biochemistry

, Volume 283, Issue 1–2, pp 123–127 | Cite as

Influence of selenium (antioxidant) on gliclazide induced hypoglycaemia/anti hyperglycaemia in normal/alloxan-induced diabetic rats

  • S. Satyanarayana
  • J. Rajad Sekhar
  • K. Eswar Kumar
  • L. Bacchus Shannika
  • Bettaiya Rajanna
  • Sharada Rajanna
Article

Abstract

Oxidative stress is involved in diabetes mellitus and its complications. Since diabetes is a stress-related disorder, supplementation with antioxidants may improve the condition. The purpose of this study is to know the effect of oral administration of selenium on blood glucose and its influence on gliclazide induced hypoglycaemia/antihyperglycaemia in normal and alloxan-induced diabetic rats. Albino rats of either sex were divided into three groups of six each. Group-I/II/III were treated with selenium 1/2 TD (0.9 μg/200 g rat)/TD (1.8 μg/200 g rat)/2TD (3.6 μg/200 g rat), respectively. Later group II was treated with gliclazide TD (1.44 mg/200 g rat)/selenium TD + gliclazide TD with a washout period of 1 week between the treatments. Diabetes was induced by alloxan monohydrate 100 mg/kg body weight i.p. A group of six rats showing fasting blood glucose levels ranging from 175–250 mg/dl were selected for the study. Rats were treated with selenium TD, gliclazide TD and selenium TD + gliclazide TD with a washout period of 1 week between the treatments. Selenium 1/2 TD and TD produced hypoglycaemia while 2TD produced hyperglycaemia. The combination of selenium TD with gliclazide TD, significantly enhanced the glucose lowering effect of gliclazide in normal and diabetic rats.

Keywords

antihyperglycaemia blood glucose diabetes gliclazide hypoglycaemia selenium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kingh H, Aubert RE, Heiman WH: Prevalence: numerical estimates and projections. Global burden of diabetes, 1995–2025. Diabetes Care 21: 1414–1431, 1998Google Scholar
  2. 2.
    Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Cittle RR, Miedmeyer HM, Byrd, Holt DD: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey 1988–1994. Diabetes Care 21: 518–524, 1998Google Scholar
  3. 3.
    Ziegler P, Drouin P: Hemobiological properties of gliclazide. J Diabetes Complicat 8(4): 235–239, 1994PubMedGoogle Scholar
  4. 4.
    Collier A, Wilson R, Bradley H, Thomson JA, Small M: Freeradical activity in type diabetes. Diabetic Med 7: 27–30, 1990PubMedGoogle Scholar
  5. 5.
    Nourooz-Zadesh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betterdige DJ: Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40: 647–653, 1997Google Scholar
  6. 6.
    Sreemantula S, Kilari EK, Vardhan VA, Jaladi R: Influence of anti oxidant (L-ascorbic acid) on tolbutamide-induced hypoglycaemia/anti hyperglycaemia in normal and diabetic rats. BMC endocrine disorders 5: 2, 2005CrossRefPubMedGoogle Scholar
  7. 7.
    Douillet C, Tabib A, Bost M, Accominoth M, Broson-Chazot F, Civatti M: Selenium in diabetes: Effects of selenium on nephropathy in type-I streptozotociun induced diabetic rats. J Trace Elem Exp Med 12: 379–392, 1999CrossRefGoogle Scholar
  8. 8.
    Lawrence DR, Bacharach AL (eds.): Evaluation of drug activities: Pharmacometrics. Vol. 1, Academic Press, New York, 1964Google Scholar
  9. 9.
    Trinder P: Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6: 24, 1969.Google Scholar
  10. 10.
    Lawrence JC, Jill SG, Eric PD, Joyle AD, Donald DL, Mark AY: Effect of antioxidant treatment on streptozotocin induced diabetic rats on endoneural blood flow, motor nerve conduction velocity and vascular reactivity of epineural arterioles of the sciatic nerve. Diabetes 50: 1927–1937, 2001Google Scholar
  11. 11.
    Oberly LW: Free radicals and diabetes. Free Radic Biol Med 5: 113–124, 1988Google Scholar
  12. 12.
    West IC: Radicals and oxidative stress in diabetes. Diabetic Med 17: 171–180, 2000CrossRefPubMedGoogle Scholar
  13. 13.
    McNeill JH, Delgatty HL, Battell ML: Insulin like effects of sodium selenate in STZ induced diabetic rats diabetes 40(12): 1675–1678, 1991Google Scholar
  14. 14.
    Ghosh R, Mukharjee B, Chatterjee M: A novel effect of selenium on streptozotocin induced diabetic mice. Diabetic Res 25(4): 1165–1171, 1994Google Scholar
  15. 15.
    Sheng Xq, Huang Kx, Xu HB: New experimental observation on the relationship of selenium and diabetes mellitus. Biol Trace Elem Res 99(1–3): 241–253, 2004PubMedGoogle Scholar
  16. 16.
    Osamu Ezaki: Insulin like effects of selenium in rat adipocytes. J Biol Chem 265(2): 1124–1128, 1990Google Scholar
  17. 17.
    Riley V: Adaptation of orbital bleeding technique to rapid serial blood studies. Proc Soc Exp Biol Med 104: 751–754, 1960PubMedGoogle Scholar
  18. 18.
    Heikkila RE: The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur J Pharmacol 44(2): 191–193, 1977CrossRefPubMedGoogle Scholar
  19. 19.
    Lizuka Y, Sakhurai E, Hichi N: Effects of selenium on serum glucose and insulin levels in diabetic rats. Nippom Yakurigakuzashi August 100(2): 151–156, 1992Google Scholar
  20. 20.
    Madar J, Dicter N, Tirosh O: Selenium antioxidant activity may impair glucose metabolism in rats. 18th International Diabetes Federation Congress, August 24–29, 2003, Paris, France. OP 20 nutrition 155Google Scholar
  21. 21.
    Viggneri R, Pezzino V, Wang KY: Comparison of the in-vitro effect of biguanides and sulfonylureas on the insulin binding of its receptors in target cells. J Clin Endocrinol Metab 54: 95–100. 1982Google Scholar
  22. 22.
    Campbell DB, Lavielle R, Nathan C: The mode of action on clinical pharmacology of gliclazide: A review. Diabetes Res Clin Pract 14(Suppl 2): S21–S36, 1991PubMedGoogle Scholar
  23. 23.
    Chiasson JL, Hamet P, Vercly M: The effect of Diamicron(R) on the secretion and action of insulin. Diabetes Res Clin Pract 14: S47–S51, 1991PubMedGoogle Scholar
  24. 24.
    Ma A, Kamp M, Bird D: The effects of long term gliclazide administration on insulin secretion and insulin sensitivity. Aus NZ J Med 19: 44–49, 1989Google Scholar
  25. 25.
    Vanhaeften TW, Vaneman TF, Gerich JE: Influence of Gliclazide on glucose stimulated insulin release in man. Metabolism 40: 751–755, 1991CrossRefGoogle Scholar
  26. 26.
    Wajchenberg BL, Santomano ATMG, Porrelli RN: Effect of sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose mediated, glucose disposal in patients with non-insulin dependent diabetes mellitus (NIDDM). Diabetes Res Clin Pract 20 : 147–154, 1993CrossRefPubMedGoogle Scholar
  27. 27.
    Ruhe RC, McDonald RB: Use of antioxidant nutrients in the prevention and treatment of type-II diabetes. J Am Coll Nutr 20(5): 363S–369S, 2001PubMedGoogle Scholar
  28. 28.
    Abdel-Wanhab YH, O'Harte FP, Mooney MH, Barnett CR, Flatt PR: Vitamin C supplementation decreases insulin glyclation and improves glucose homeostasis in obese hyperglycaemic (ob/ob) mice metabolism 51: 514–517, 2002Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • S. Satyanarayana
    • 1
    • 3
  • J. Rajad Sekhar
    • 1
  • K. Eswar Kumar
    • 1
  • L. Bacchus Shannika
    • 2
  • Bettaiya Rajanna
    • 2
  • Sharada Rajanna
    • 2
  1. 1.University College of Pharmaceutical SciencesAndhra UniversityVisakhapatnamIndia
  2. 2.Department of Biological SciencesAlcorn State UniversityLormannU.S.A.
  3. 3.Pharmacology Division, University College of Pharmaceutical SciencesAndhra UniversityVisakhapatnamIndia

Personalised recommendations